Recent Innovations and Nano-Delivery of Actinium-225: A Narrative Review.
actinium-225
nanotechnology
radiopharmaceuticals
recoiling of daughters
targeted radionuclide therapy
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
13 Jun 2023
13 Jun 2023
Historique:
received:
17
04
2023
revised:
13
05
2023
accepted:
12
06
2023
medline:
28
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
The actinium-225 (
Identifiants
pubmed: 37376167
pii: pharmaceutics15061719
doi: 10.3390/pharmaceutics15061719
pmc: PMC10304099
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Semin Nucl Med. 2020 Mar;50(2):119-123
pubmed: 32172796
Theranostics. 2022 Oct 17;12(17):7203-7215
pubmed: 36438496
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):129-138
pubmed: 30232539
Chemistry. 2020 Sep 4;26(50):11435-11440
pubmed: 32588455
Pharmaceutics. 2022 Dec 30;15(1):
pubmed: 36678756
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3581-3592
pubmed: 35384462
Tumour Biol. 2012 Jun;33(3):573-90
pubmed: 22143940
Cancer Biother Radiopharm. 2022 Jun;37(5):355-363
pubmed: 35695807
Pharmaceutics. 2020 Feb 21;12(2):
pubmed: 32098286
EJNMMI Radiopharm Chem. 2022 Nov 4;7(1):29
pubmed: 36333648
J Nanopart Res. 2018;20(3):83
pubmed: 29576738
Appl Radiat Isot. 2017 Oct;128:183-189
pubmed: 28734193
Bioorg Med Chem Lett. 2010 Feb 1;20(3):927-31
pubmed: 20045643
Nucl Med Commun. 2015 May;36(5):414-22
pubmed: 25646703
J Clin Endocrinol Metab. 2001 Apr;86(4):1568-73
pubmed: 11297585
Q J Nucl Med Mol Imaging. 2020 Sep;64(3):265-277
pubmed: 32441067
Sci Adv. 2021 Oct 22;7(43):eabk0273
pubmed: 34669462
Am J Clin Oncol. 2012 Apr;35(2):167-77
pubmed: 21127414
Nanomaterials (Basel). 2020 Jul 13;10(7):
pubmed: 32668687
Front Med (Lausanne). 2015 Mar 17;2:12
pubmed: 25853132
Indian J Nucl Med. 2020 Oct-Dec;35(4):299-304
pubmed: 33642753
Materials (Basel). 2021 Aug 24;14(17):
pubmed: 34500873
J Control Release. 2018 Oct 10;287:177-193
pubmed: 30086338
Curr Radiopharm. 2011 Oct;4(4):306-20
pubmed: 22202153
N Engl J Med. 2021 Sep 16;385(12):1091-1103
pubmed: 34161051
Cancer Res. 2003 Aug 15;63(16):5084-90
pubmed: 12941838
Semin Nucl Med. 2020 Mar;50(2):162-170
pubmed: 32172801
Curr Radiopharm. 2018;11(3):192-199
pubmed: 29793418
Pharmaceutics. 2021 May 13;13(5):
pubmed: 34068206
Nat Biotechnol. 2018 Dec 6;36(12):1125-1127
pubmed: 30520873
J Nucl Med. 2015 Jun;56(6):897-900
pubmed: 25931476
Nat Rev Drug Discov. 2020 Sep;19(9):589-608
pubmed: 32728208
Mol Pharm. 2020 Sep 8;17(9):3553-3566
pubmed: 32787284
J Control Release. 2021 Feb 10;330:726-737
pubmed: 33428985
Cell Death Differ. 2002 Jun;9(6):593-4
pubmed: 12032666
Bioconjug Chem. 2007 Nov-Dec;18(6):2061-7
pubmed: 17935286
Anal Chem. 2005 Oct 1;77(19):6288-91
pubmed: 16194090
EJNMMI Radiopharm Chem. 2021 Dec 20;6(1):38
pubmed: 34928478
J Clin Oncol. 2002 May 15;20(10):2453-63
pubmed: 12011122
Cancer Biother Radiopharm. 2018 Oct;33(8):336-348
pubmed: 29889562
Bioconjug Chem. 2011 Sep 21;22(9):1784-92
pubmed: 21851119
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1393-1407
pubmed: 28451827
Clin Cancer Res. 2022 May 13;28(10):2030-2037
pubmed: 35247915
Nat Commun. 2016 Aug 17;7:12312
pubmed: 27531582
Cancer Biother Radiopharm. 2002 Apr;17(2):219-31
pubmed: 12030116
Cancer Biother Radiopharm. 2020 Aug;35(6):446-458
pubmed: 32302510
Int J Pharm. 2021 Sep 5;606:120870
pubmed: 34245844
Cancer Biother Radiopharm. 2014 Feb;29(1):34-41
pubmed: 24102173
Curr Radiopharm. 2023;16(2):133-139
pubmed: 36464880
Sci Rep. 2019 Aug 12;9(1):11671
pubmed: 31406320
Cancers (Basel). 2021 Apr 20;13(8):
pubmed: 33923965
Indian J Nucl Med. 2021 Apr-Jun;36(2):114-119
pubmed: 34385780
Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3627-3638
pubmed: 35556158
Lancet Oncol. 2018 Jun;19(6):825-833
pubmed: 29752180
Clin Cancer Res. 2004 Jul 1;10(13):4489-97
pubmed: 15240541
Curr Radiopharm. 2022;15(2):96-103
pubmed: 34250876
Pract Radiat Oncol. 2022 Jul-Aug;12(4):312-316
pubmed: 35717046
Nanomaterials (Basel). 2022 Feb 09;12(4):
pubmed: 35214911
Adv Drug Deliv Rev. 2008 Sep;60(12):1371-82
pubmed: 18514364
Lancet Oncol. 2020 Mar;21(3):e146-e156
pubmed: 32135118
J Nucl Med. 2004 Feb;45(2):253-60
pubmed: 14960644
J Nanobiotechnology. 2019 Aug 21;17(1):90
pubmed: 31434562
Curr Drug Deliv. 2010 Apr;7(2):168-74
pubmed: 20158485
Curr Radiopharm. 2012 Jul;5(3):221-7
pubmed: 22642390
Nucl Med Biol. 2004 May;31(4):441-9
pubmed: 15093814